Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd's latest stock split occurred on Jun 5, 2023
The company executed a 7-for-5 stock split, meaning that for every 5 shares held, investors received 7 new shares.
Before the split, Beijing Wantai Biological Pharmacy Enterprise Co Ltd traded at 67.3643 per share. Afterward, the share price was about 64.73.
The adjusted shares began trading on Jun 5, 2023. This was Beijing Wantai Biological Pharmacy Enterprise Co Ltd's 3rd stock split, following the previous one in Apr 21, 2022.
1S9
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
Glance View
In the bustling corridors of Beijing's biotechnology landscape, Beijing Wantai Biological Pharmacy Enterprise Co Ltd has emerged as a significant player, weaving a narrative of innovation and growth. Founded in 1991, Wantai has dedicated itself to the research, development, production, and marketing of in vitro diagnostic tests and vaccines. The company's strategic focus on infectious disease diagnostics has positioned it as a crucial contributor to public health efforts globally. With its widespread product portfolio covering respiratory diseases, sexually transmitted infections, and enteric pathogens, the firm's offerings are integral for medical professionals who rely on Wantai's reliable and precise diagnostic tools to make critical healthcare decisions. Wantai's success isn't merely confined to market presence. The company prides itself on a robust pipeline of vaccine development, targeting diseases neglected by the mainstream pharmaceutical industry. Notably, it gained significant attention during the COVID-19 pandemic for developing diagnostic tests that became pivotal in many countries' strategies to manage and track the virus. The firm's revenue streams are diversified across both domestic and international sales, bolstered by strategic partnerships and collaborations with global health organizations. By remaining at the frontier of scientific advancement and healthcare needs, Wantai thrives not just through innovation but also through its commitment to solving some of the world's most pressing health challenges.
You don't have any saved screeners yet